Plagues have been described since humans began to recall their history. Despite the development of antimicrobials, vaccines, and other technologic advances, infection is a leading cause of death in the developing world, and outbreaks of infectious diseases continue to influence global events, even in the twenty-first century. The appearance of emerging infectious diseases (those caused by a newly recognized agent) and reemerging infectious diseases (those caused by a known agent that has developed enhanced pathogenicity or dramatically increased in incidence) may be due to multiple factors, but perhaps the most important are the alteration of human and nonhuman ecology and environmental change. Despite the devastating effect that unrecognized and unanticipated diseases may have on the human population, the concept of "emerging infections" did not coalesce until the 1990s. In 1992, the Institute of Medicine (IOM) of the National Academy of Sciences published a report that called for the establishment of programs to effectively identify, monitor, and respond to all infectious agents, including newly recognized pathogens such as human immunodeficiency virus (HIV) and antimicrobial-resistant bacteria. The 1992 IOM report recommended strengthening communicable disease surveillance in the United States at the local, state, and federal levels; establishing a comprehensive global network for infectious disease surveillance; and supporting research to improve infectious disease detection and response. In 2003, the IOM evaluated the progress of efforts to implement their recommendations and reported that the global infrastructure to support response to emerging and reemerging infections continued to be neglected, particularly in developing regions, where many previously unrecognized human infections first appear.

Much has happened in the United States and globally since the publication of that 1992 IOM report: burgeoning antimicrobial resistance, the North American emergence of West Nile virus (WNV), the intentional distribution of *Bacillus anthracis,* and a vaccine campaign for a vanquished disease (smallpox) rumored to be the next weapon of mass destruction. More recently, widespread outbreaks of severe acute respiratory syndrome (SARS) and avian influenza, both initially thought to portend the next pandemic, were upstaged when a novel swine influenza caused the first pandemic of the twenty-first century.

The confluence of human and nonhuman ecology and environmental disturbance sets the stage for the prototypical emerging or reemerging infectious disease: a zoonosis, or disease caused by an agent that typically infects another species but has made an evolutionary transition that enables it to infect humans. Two recent reports that reviewed trends in emerging infections identified several patterns of association: emerging infectious diseases of temperate regions tend to be associated with domesticated animals, advanced agriculture, and healthcare technologies, whereas those originating in tropical regions are more typically linked to human interaction with wild animals or exposure to insect vectors. Both reports called for renewed efforts to establish programs for surveillance and investigation of emerging infections that focus on these associations, allocating resources to detect novel or reemerging infections in developing regions with the greatest biodiversity and interaction between wildlife and humans.

Even a partial list of emerging and remerging infections of the last 30 years includes pathogens too numerous for all to be covered in this section: HIV, hepatitis C (formerly non-A, non-B hepatitis) virus, avian and swine influenza A viruses, the SARS coronavirus, Sin Nombre virus, WNV, dengue viruses, and the agent of variant Creutzfeldt-Jakob disease; *B. anthracis, Escherichia coli O157:H7* and other enterohemorrhagic *E. coli, Francisella tularensis, Vibrio cholerae* O139*,* and *Yersinia pestis;* and *Cryptosporidium parvum* and *Cyclospora cayetanensis.* In addition, a number of pathogens have developed significant resistance to antimicrobials: *Neisseria gonorrhoeae, Salmonella* and *Shigella* species, *Staphylococcus* species, *Streptococcus pneumoniae, Mycobacterium tuberculosis,* bacterial species responsible for healthcare-associated infections, and *Plasmodium falciparum* and *Plasmodium vivax.*

The chapters chosen for this section are excellent reviews of the epidemiology of several of these infections. In addition, they outline the diagnostic approach to each disease, discuss the clinical management of patients, and describe public health interventions to prevent and control the infections.

*Bacillus anthracis* is a zoonosis that occurs globally but is extremely rare in North America and Europe. *B. anthracis* is easily transmissible*,* is highly lethal if untreated, and has great potential to cause social disruption, as evidenced by the 2001 bioterrorist attack. For this reason, anthrax is an excellent example of a Category A Select Agent, as designated by the Centers for Disease Control and Prevention.

The influenza A virus is the prototypical reemerging zoonosis and an agent with great pandemic potential. Although influenza A virus has infected mammals and birds for millennia, changes in the viral genetic structure may enable a novel influenza A virus to cause widespread human disease. Each novel virus\'s pathogenicity is unpredictable, and several influenza A pandemics of varying severity have occurred since the devastating pandemic of 1918.

SARS is caused by a coronavirus (SARS-CoV) that was first recognized during a widespread but brief global outbreak that began in November 2002 and rapidly evaporated in July 2003. Coronaviruses very closely related to SARS-CoV have been isolated from bats and other mammals (notably, those traded in live animal markets as food), and SARS is most likely a zoonotic infection. The rapid, extensive global response to SARS reflects the enormous public health resources required to deal with a rapidly emerging infection.

Worldwide, more than 2 billion people are infected with *M. tuberculosis.* Drug-resistant tuberculosis is emerging as a significant threat to developing regions of the world, places already being devastated by the HIV pandemic. Where resources are most limited, the potential public health burden, morbidity, and mortality from drug-resistant tuberculosis and HIV are staggering.

Finally, two infections exemplify the impact of environmental change on human disease: tularemia and WNV disease. Tularemia is classically associated with rural hunting activities and typically manifests as oculoglandular disease; however, an increasing number of cases of inhalational tularemia have been reported in suburban lawn-mowing residents of Martha\'s Vineyard, Massachusetts, where infected rabbits were imported by hunting clubs in the 1920s and 1930s. Until 1999, WNV did not occur in the Americas;, however, since the virus\'s apparent introduction into New York City in 1999, it has spread rapidly across the United States and Canada to become the most common arthropod-borne viral disease in North America.
